Epithelial ovarian cancer (EOC) is a deadly cancer, and its prognosis has not been changed significantly during several decades. To seek new therapeutic targets for EOC, we performed an in vivo dropout screen in human tumor xenografts using a pooled shRNA library targeting thousands of druggable genes. Then, in follow-up...
from Genetics via xlomafota13 on Inoreader http://ift.tt/2x1nnBl
via IFTTT
Τρίτη 29 Αυγούστου 2017
In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer [Genetics]
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.